About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Lyme Borreliosis and Early Cutaneous Diagnostic | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT02414789

Lyme Borreliosis and Early Cutaneous Diagnostic

Test and evaluate a new diagnostic method (SRM-MS/MS: Selected Reaction Monitoring- Mass spectrometry) for Lyme Borreliosis on human skin biopsies. Patients included are those with the early skin mani...

Lead sponsor: University Hospital, Strasbourg, France•7 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University Hospital, Strasbourg, France

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Erythema migrant as criteria EUCALB or atypical form associated to tick's sting
•Patient having signed a consent
•Patient affiliated to a social security scheme

Exclusion Criteria

•Prior treatment with antibiotics
•Erythema migrans on the face
•Bleeding disorders
•Anticoagulant treatment
•Inability to give clear information (subject in an emergency situation, understanding of the topic difficulty, ...)

Related studies

RECRUITINGPhase 3

Different Amoxicillin Treatment Regimens in Erythema Migrans Patients

NCT03966014 · Erythema Migrans

RECRUITINGPhase 4

Effect of Saccharomyces Boulardii CNCM I-745 on Gut Microbiota in Patients Undergoing Antibiotic Therapy (in the Context of Erythema Migrans (Early Skin Form of Lyme Borreliosis))

NCT06451913 · Erythema Migrans of Lyme Disease

Analysis of Lyme Disease Lesions

NCT00132327 · Erythema Migrans Lesions, Erythema Migrans

COMPLETEDPhase 4

Comparing 3 Antibiotic Regimes for Erythema Migrans in General Practice

NCT01368341 · Erythema Migrans, Erythema Chronicum Migrans, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 1, 2025Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment84

Start dateAug 2015

Last updatedOct 1, 2025

Condition

Erythema Migrans

Locations shown

Centre Hospitalo-Universitaire Jean Minjoz

Besançon

Centre Hospitalier William Morey

Chalon-sur-Saône

Hôpital Pasteur

Colmar

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 1, 2025Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions